ITL Limited, a diversified healthcare company and owner of ITL Healthcare which produces quality invasive blood pressure monitoring systems, is pleased to announce a new five year contract with Macquarie University Hospital (MUH), Australia’s first private not-for-profit teaching hospital, located at Macquarie University in Sydney.
The contract is to supply ITL Healthcare’s Vedette range of its very latest quality invasive blood pressure monitoring systems and is estimated to be worth $0.5m. The agreement includes two new innovative product solutions that meet best clinical practice:
1. nABSS (needle-free closed Arterial Blood Sampling System) is a system that helps to prevent needle-stick injuries, Hospital Associated Infections and minimises blood loss when taking blood samples during invasive blood pressure monitoring, and
2. CMS (Cable Management System) reduces the potential for errors by reducing the number of cables running from multiple transducers to the hospitals monitors.
MUH uses the very latest innovative technology, much of which is unavailable anywhere else in the country. Their stunning 183 bed facility incorporates the very latest design principles, and they recognise the therapeutic role the healthcare environment plays on their patients, visitors and staff.
Bill Mobbs, Executive Chairman commented “This new contract shows ITL Healthcare’s innovative products are very market relevant. The division also recently won a 3-year contract extension with Tasmania’s Department of Health and Human Services to continue to provide existing innovative products within its Vedette range. ITL Healthcare’s innovative approach is aligned very closely to ITL’s overall strategy and the Board is very happy to see its continued growth.”
